However, this initial shift towards a more differentiated phenotype early in tumor progression appears then to be followed by a reacquisition of mesenchymal features in more advanced ovarian tumors, involving a secondary loss of E-cadherin [26], [27], [28]. This evidence concerns the gene CDH1 and neoplasm.